Gherman, A., Căinap, C., Constantin, A.-M., Cetean, S. and Căinap, S. 2017. Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab. Medicine and Pharmacy Reports. 90, 4 (Oct. 2017), 377-384. DOI:https://doi.org/10.15386/cjmed-745.